FDA Adverse Event Injury Summary report: N

BI-METRIC/X POR NC 13X145

MDR report key: 9560173 · Received January 7, 2020

Report

Report Number
0001825034-2020-00050
Event Type
Injury
Date Received
January 7, 2020
Date of Event
June 10, 2019
Report Date
January 16, 2020
Manufacturer
ZIMMER BIOMET, INC.
Product Code
KWA
PMA / PMN Number
K042037
Removal / Correction Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

UPON RECEIPT OF ADDITIONAL INFORMATION, IT HAS BEEN DETERMINED THAT THIS DEVICE DID NOT CAUSE OR CONTRIBUTE TO THE REPORTED EVENT. THE INITIAL REPORT WAS FORWARDED IN ERROR AND SHOULD BE VOIDED.

Description of Event or Problem · 0

NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCTS: M2A-MAGNUM PF CUP 58ODX52ID, PN US157858, LN 394870, M2A-MAGNUM MOD HD SZ 52MM, PN 157425, LN 203070, M2A-MAGNUM 52-60MM TPR INS STD, PN 139268, LN 810490. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT. PLEASE SEE REPORTS: 0001825034-2019-00539, 0001825034-2019-00540. CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION, AS THE DEVICE LOCATION IS UNKNOWN. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT UNDERWENT AN INITIAL LEFT TOTAL HIP ARTHROPLASTY. SUBSEQUENTLY, THE PATIENT UNDERWENT REVISION APPROXIMATELY 14 YEARS AFTER THE INITIAL SURGERY DUE TO PAIN, PSEUDOTUMOR, ACETABULAR PROTRUSIO, AND ELEVATED METAL IONS. DURING THE REVISION, EXTENSIVE METALLOSIS, SCAR TISSUE, AND TISSUE DAMAGE WERE NOTED IN ADDITION TO SIGNIFICANT BONE LOSS AND OSTEOLYSIS. ALL COMPONENTS WERE REVISED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
21160 BI-METRIC/X POR NC 13X145 PROSTHESIS, HIP KWA ZIMMER BIOMET, INC. N/A 517600

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R SEE H10 NARRATIVE.